Sistemi microparticellari per somministrazione orale di sostanze biologicamente attive.

Proteins administered orally must pass through the gastric environment in order to reach their site of absorption in the intestine. How to protect these exogenously administered proteins from the damaging effects of gastric acid and pepsin proteolytic activity, which often induce irreversible structural and functional alterations to the molecules, is an intriguing challenge. These microparticle systems offer promise for applications in human and veterinary medicine as well as in human and animal nutrition.